Daniel Ontaneda - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Daniel Ontaneda

Showing results (191-200 of 193) with videos related to

Pageof 20

Sort By:

You have reached the last page of results.This site can display upto 193 results.

Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)Emma C Tallantyre, Sarah M Planchon, Harriet Howard, et al.

The Lancet. Neurology|September 20, 2025

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, et al.

The New England Journal of Medicine|August 30, 2018

Phase 2 Trial of Ibudilast in Progressive Multiple SclerosisRobert J Fox, Christopher S Coffey, Robin Conwit, et al.

Pageof 20

Search research articles

Showing results (191-200 of 193) with videos related to

Sort By:

Pageof 20

You have reached the last page of results.This site can display upto 193 results.

Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)Emma C Tallantyre, Sarah M Planchon, Harriet Howard, et al.

The Lancet. Neurology|September 20, 2025

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, et al.

The New England Journal of Medicine|August 30, 2018

Phase 2 Trial of Ibudilast in Progressive Multiple SclerosisRobert J Fox, Christopher S Coffey, Robin Conwit, et al.

Pageof 20